EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of biomarkers and prediction of upstream miRNAs in diabetic nephropathy

Dapeng Yin, Zhixin Guo, Xinyu Zhang

Frontiers in Endocrinology · 21.02.2023 · 14

DOI: 10.3389/fendo.2023.1144331 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Endocrinology, online erschienen am 21.02.2023. Verfasst von Dapeng Yin und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, The Second Medical Hospital of Shanxi Medical University, Taiyuan, Shanxi, China. Hauptthemen laut MEDLINE: MicroRNAs, Diabetic Nephropathies, Diabetes Mellitus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To explore biomarkers of diabetic nephropathy (DN) and predict upstream miRNAs.

Methods

The data sets GSE142025 and GSE96804 were obtained from Gene Expression Omnibus database. Subsequently, common differentially expressed genes (DEGs) of renal tissue in DN and control group were identified and protein-protein interaction network (PPI) was constructed. Hub genes were screened from in DEGs and made an investigation on functional enrichment and pathway research. Finally, the target gene was selected for further study. The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic efficiency of target gene and predicted its upstream miRNAs.

Results

130 common DEGs were obtained through analysis, and 10 Hub genes were further identified. The function of Hub genes was mainly related to extracellular matrix (ECM), collagen fibrous tissue, transforming growth factor (TGF) -β, advanced glycosylation end product (AGE) -receptor (RAGE) and so on. Research showed that the expression level of Hub genes in DN group was significantly higher than that in control group. (all P<0.05). The target gene matrix metalloproteinase 2 (MMP2) was selected for further study, and it was found to be related to the fibrosis process and the genes regulating fibrosis. Meanwhile, ROC curve analysis showed that MMP2 had a good predictive value for DN. miRNA prediction suggested that miR-106b-5p and miR-93-5p could regulate the expression of MMP2.

Conclusion

MMP2 can be used as a biomarker for DN to participate in the pathogenesis of fibrosis, and miR-106b-5p and miR-93-5p may regulate the expression of MMP2 as upstream signals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsDiabetic NephropathiesDiabetes MellitusHumansMatrix Metalloproteinase 2Gene Expression ProfilingBiomarkersFibrosis

Stichwörter der Autor:innen

MMP2bioinformaticsdiabetic nephropathyfibrosismiRNA

Substanzen

MicroRNAsMatrix Metalloproteinase 2Biomarkers

Autor:innen und Institutionen

  • Department of Endocrinology, The Second Medical Hospital of Shanxi Medical University, Taiyuan, Shanxi, China.

Zitieren

APA

Yin, D., Guo, Z., & Zhang, X. (2023). Identification of biomarkers and prediction of upstream miRNAs in diabetic nephropathy. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1144331

Vancouver

Yin D, Guo Z, Zhang X. Identification of biomarkers and prediction of upstream miRNAs in diabetic nephropathy. Frontiers in Endocrinology. 2023;14. doi:10.3389/fendo.2023.1144331

BibTeX
@article{Yin2023,
  author = {Yin, Dapeng and Guo, Zhixin and Zhang, Xinyu},
  title = {Identification of biomarkers and prediction of upstream miRNAs in diabetic nephropathy},
  journal = {Frontiers in Endocrinology},
  year = {2023},
  volume = {14},
  doi = {10.3389/fendo.2023.1144331}
}
Kostenlos starten →